This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (67)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Dermatology  • Dermatologic Disorders  • Bioterrorism  • Dermatologic Disorders, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

John M. Neff, MD; J. Michael Lane, MD,MPH; Vincent A. Fulginiti, MD; Donald A. Henderson, MD,MPH

JAMA. 2002;288:1901-1905.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Concern that smallpox virus might be used as a biological weapon has led to proposals that smallpox vaccination be offered to at least some of the US population.^1-4 In June 2002, the US Department of Health and Human Services' Advisory Committee on Immunization Practice recommended that vaccination be offered to limited numbers of health care personnel who may be investigating possible cases of smallpox and to those who might be caring for patients in selected hospitals.⁵ On September 23, 2002, the Centers for Disease Control and Prevention (CDC) distributed detailed operational and logistic guidelines for implementing a large-scale volunteer smallpox vaccination program in response to introduction of smallpox as an act of terrorism.⁶ These events raise concern about the frequency of serious adverse events, including death, that may occur from vaccination. These have been . . . [Full Text of this Article]

Reports Before the 1960s

Author Affiliations: Center for Children With Special Needs, Children's Hospital and Regional Medical Center, and the Department of Pediatrics, University of Washington School of Medicine, Seattle (Dr Neff); formerly from the Smallpox Eradication Program, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Lane); University of Arizona School of Medicine, Tucson (Dr Fulginiti); and Johns Hopkins University Center for Civilian Biodefense Strategies, Baltimore, Md (Dr Henderson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Characterization and Use of Mammalian-Expressed Vaccinia Virus Extracellular Membrane Proteins for Quantification of the Humoral Immune Response to Smallpox Vaccines
Garcia et al.
CVI 2007;14:1032-1044.
ABSTRACT | FULL TEXT  

Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
Casey et al.
JAMA 2005;294:2734-2743.
ABSTRACT | FULL TEXT  

Modified Vaccinia Virus Ankara Immunization Protects against Lethal Challenge with Recombinant Vaccinia Virus Expressing Murine Interleukin-4
McCurdy et al.
J. Virol. 2004;78:12471-12479.
ABSTRACT | FULL TEXT  

Uncertain Benefit: The Public Policy of Approving Smallpox Vaccine Research
Quigley
AJPH 2004;94:943-947.
ABSTRACT | FULL TEXT  

Secondary and Tertiary Transfer of Vaccinia Virus Among U.S. Military Personnel--United States and Worldwide, 2002-2004
Arch Dermatol 2004;140:629-630.
FULL TEXT  

Smallpox: Clinical Features, Prevention, and Management
Guharoy et al.
The Annals of Pharmacotherapy 2004;38:440-447.
ABSTRACT | FULL TEXT  

Tertiary Contact Vaccinia in a Breastfeeding Infant
Garde et al.
JAMA 2004;291:725-727.
ABSTRACT | FULL TEXT  

Eczematous Skin Disease and Recall of Past Diagnoses: Implications for Smallpox Vaccination
Naleway et al.
ANN INTERN MED 2003;139:1-7.
ABSTRACT | FULL TEXT  

Smallpox and Smallpox Vaccination
Letai et al.
NEJM 2003;348:1920-1925.
FULL TEXT  

Smallpox: An Update for Nurses
Constantin et al.
Biol Res Nurs 2003;4:282-294.
ABSTRACT  

Smallpox Vaccine: The Good, the Bad, and the Ugly
Belongia and Naleway
Clin Med Res 2003;1:87-92.
ABSTRACT | FULL TEXT  

Inpatients at Risk of Contact Vaccinia From Immunized Health Care Workers
Smith et al.
JAMA 2003;289:1512-1513.
FULL TEXT  

Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options
Lane and Goldstein
ANN INTERN MED 2003;138:488-493.
ABSTRACT | FULL TEXT  

Risk of Cutaneous Vaccinia From Health Care Workers Who Receive Smallpox Vaccine
Mermel
JAMA 2003;289:844-845.
FULL TEXT  

How Contagious Is Vaccinia?
Sepkowitz
NEJM 2003;348:439-446.
FULL TEXT  

A Different View of Smallpox and Vaccination
Mack
NEJM 2003;348:460-463.
FULL TEXT